Vertical transmission of human immunodeficiency virus: Six years of evolution (1987-1992);Transmisión vertical del virus de la inmunodeficiencia humana: Seis años de evolución (1987-1992)

Medicina Clinica

Volumn 107, Issue 14, 1996, Pages 530-532

  Guasch, Claudia Fortuny ^a   Ruiz, Emilia Sánchez ^b,d   Escursell, Oriol Coll ^c   González, Rafael Jiménez ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b GENERALITAT DE CATALUNYA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Servei Catala de la Salut   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; PRESCHOOL CHILD; SPAIN; STATISTICS;

CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; HIV INFECTIONS; HUMANS; INFANT; SPAIN;

EID: 0030603264     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. World Health Organization. The current global situation of the HIV/AIDS pandemic. Wkly Epidemiol Rec 1995; 70: 5-8.
2. Ministerio de Sanidad y Consumo. Vigilancia del sida en España. Informe trimestral n.o 4, 1994.
3. Chin J. Public health surveillance of AIDS and HIV infections. WHO Bull 1990; 68: 529-536.
4. Centers for Disease Control. Classification system tor human Immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987; 36: 225-230, 235.
5. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36 (Supl 2-S): 3-16.
6. Dabis F, Msellati P, Dunn D, Lepage P, Newell ML, Peckham C et al. Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues. Ghent (Belgium), 17-20 February 1992. AIDS 1993; 7: 1.139-1.148.
7. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologie research. Principles and quantitative methods. Nueva York: Van Nostrand Reinhold Company Inc., 1982.
8. Generalitat de Catalunya. Departament de Sanitat i Seguretat Social. Vigilància epidemiológica de la sida a Catalunya. Butll Epidemiol Catal 1995; 16: 13-15, 21-23.
9. Coll O, Torné A, Ercilla G, Sánchez E. Temporal trend of HIV infection among pregnant women in a reference hospital in Barcelona. AIDS 1993; 7: 443-444.
10. European Collaborative Study. Children born to women with HIV infection: natural history and risk of transmission Lancet 1991; 337: 253-260.
11. Blanche S, Rouzioux C, Moscato MG, Veber F, Mayaux MJ, Jacomet C et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989; 320: 1.643-1.648.
12. Gabiano C, Tovo PA, De Martino M, Galli L, Giaquinto C, Loy A et al. Mother to child transmission of HIV: risk of infection and correlates of transmission. Paediatrics 1992; 90: 362-374.
13. Español T, Curell N, Bertrán JM, Fortuny C, Munoz F, Jiménez R et al. Transmisión materno-infantil de la infección por el virus de la inmunodeficiencia humana (VIH) en Cataluña y Baleares. An Esp Pediatr 1989; 30: 365-368.
14. Canosa CA, Delgado A, García Martín F, Llorens J, Omeñaca F, Ruiz Contreras J et al. SIDA pediátrico en España. An Esp Pediatr 1990; 33 (Supl 42): 141-149.
15. Sánchez E, Casabona J, Fortuny C, Curell N. Marti C y colaboradores de los centras asistenciales. Transmisión vertical del VIH: epidemiologia descriptiva, factores de riesgo y supervivencia (II). An Esp Pediatr 1992; 37: 443-448.
16. Allain SP, Laurian Y, Einstein MH, Braun BP, Delaney SR, Stephens JE et al. Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance. Blood 1991; 77: 1.118-1.123.
17. Dimitrov DH, Meinick JL, Hollingen B. Culture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells. J Clin Microbiol 1990; 28: 734-737.
18. Castilla J, Tello O, Sánchez MF. Evolución del patron epidemiológico de los casos de sida en Espana. Gac Sanit 1995; 9: 159-165.
19. Sperling RS, Stratton P, O'Sullivan MJ, Boyer P, Watts DH, Lambert JS et al. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med 1992; 326: 857-861.
20. Centers for Disease Control. Zidovudine for the prevention of HIV transmission from mother to infant. Effectiveness in disease and injury prevention. MMWR 1994; 43: 286-287.
21. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1.173-1.180.
22. Centers for Disease Control. Recommendations of the US Public Healfh Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994; 43 (RR-11): 1-20.
23. Blanche S, Mayaux MJ, Rouzioux C, Teglas JP. Firtion G, Monpoux F et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994; 330: 308-312.
24. Coll O, Martinez de Tejada B, Sánchez E. Papel de la zidovudina y de la cesárea en la prevención de la transmisión vertical del VIH. Med Clin (Barc) 1995; 104: 183-184.